Clinical Report: The Gut Microbiome Shift in Lupus and Its Implications
Overview
In lupus-prone mice, the gut microbiome shifts from fiber catabolism to utilizing the host's mucin, leading to the depletion of Faecalibacterium prausnitzii. Restoration of this bacterium was associated with changes in microbiome composition.
Background
Understanding the gut microbiome's role in systemic lupus erythematosus (SLE) is crucial as it may influence disease progression and treatment responses. Recent studies indicate that alterations in microbial metabolism can have significant implications for autoimmune conditions like lupus.
Data Highlights
| Parameter | Before Treatment | After Treatment |
|---|---|---|
| Disrupted Species Restored | 0 | 17 of 86 |
| Depleted Carbohydrate-Degrading Enzymes | 0% | ~40% |
| Colonic Regulatory T Cells | Low | Increased |
| Th17 Cells | High | Decreased |
| Anti-dsDNA Antibodies | High | Lowered |
| Renal Pathology Scores | High | Lowered |
Key Findings
- The gut microbiome in lupus shifts from fiber catabolism to mucin utilization.
- Faecalibacterium prausnitzii depletion is associated with this metabolic shift.
- Restoration of F. prausnitzii in lupus-prone mice improved microbiome composition and immune function.
- Increased regulatory T cells and decreased Th17 cells were observed post-treatment.
- Lower anti-dsDNA antibodies and renal pathology scores were noted after F. prausnitzii administration.
Clinical Implications
The study indicates that targeting the gut microbiome may offer a novel approach to managing lupus.
Conclusion
The findings highlight the importance of the gut microbiome in lupus pathogenesis.
Related Resources & Content
- Multiomics-guided discovery of protective microbiome signatures in lupus-prone mice treated with Faecalibacterium prausnitzii, Nature Communications, 2026
- New Lupus SLE Clinical Practice Guideline Released | ACR Convergence 2025 | American College of Rheumatology
- conexiant — Side Effects: The Hidden Variable
- Obesity Surgery — New Perspectives on Nutrient Detection and Gut-Brain Interaction in the Context of Surgical and Experimental Approaches to Obesity Management
- the new gastroenterologist — Gut abnormalities persist even in Crohn's remission
- Journal of Gastroenterology — The Interplay of Diet, Microbiota, and Genetic Factors in Inflammatory Bowel Disease Development
- New Lupus SLE Clinical Practice Guideline Released | ACR Convergence 2025 | American College of Rheumatology
- Multiomics-guided discovery of protective microbiome signatures in lupus-prone mice treated with Faecalibacterium prausnitzii | Nature Communications
- O3 Changes in gut microbiota after synbiotic supplementation in patients with systemic lupus erythematosus: a randomised, double-blind, placebo-controlled trial | Lupus Science & Medicine
This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.